Clinical Trials Directory

Trials / Terminated

TerminatedNCT02915991

User Evaluation Study of SyncVision System With Software v4.X

Prospective, Single Arm, Open Label, User Evaluation Sudy of SyncVision System With Software v4.X

Status
Terminated
Phase
Study type
Observational
Enrollment
35 (actual)
Sponsor
Volcano Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, single-arm, unblinded, case observation study evaluating a commercially released 'Conformité Européenne' (CE)-mark co-registration software system along-side of a commercially- released CE-mark coronary physiology and X-ray system during routine clinical workflow. The purpose of this study is to collect Professional user feedback regarding clinical utility of the SyncVision 4.X system.

Detailed description

The PREPARE II study will enroll a maximum of 200 patients in up to 5 sites. No follow-up will be performed. The PREPARE II study will only collect data during diagnostic angiogram or percutaneous coronary intervention (PCI) procedure, when performed as per standard hospital care.

Conditions

Timeline

Start date
2016-11-01
Primary completion
2017-08-01
Completion
2017-08-01
First posted
2016-09-27
Last updated
2018-05-14

Locations

2 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT02915991. Inclusion in this directory is not an endorsement.

User Evaluation Study of SyncVision System With Software v4.X (NCT02915991) · Clinical Trials Directory